Similasan Reisekrankheit, Globuli
7680678120014
CH-67812
Globuli
Associated product:
SIMILASAN Maux de voyage glob fl 15 g
1 / 3
google
Article details
- Package size
- 15.0
- Selling units
- 15
- Measure
- g
- Galenic form
- Globuli
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
600.0 MG | Substance | HNIDK |
Authorization holder
Similasan AG
8916 Jonen
Authorization information
- Swissmedic authorization number
- 67812
- Drug name
- Similasan Reisekrankheit, Globuli
- Galenic form
- GLO
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 16/12/2021
- Authorization expiration date
- 15/12/2026
- IT Number
- 20.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- SIMILASAN Maux de voyage glob fl 15 g
- Description (DE)
- SIMILASAN Reisekrankheit Glob Fl 15 g
- Market launch
- 16/12/2021
- Narcotic (BTM)
- No
Other package sizes (1)
None
4.5 G
GTIN: None